Clinical research studies (i.e. Clinical trials), explore new methods to prevent, detect, or treat diseases and medical conditions. They determine if the new treatments being studied have efficacy and safety. Without these studies, important medical progress wouldn’t occur. The details below provide information about two clinical research studies for schizophrenia: one involving an investigational medication for cognitive impairment and another using a mobile application for negative symptoms.

About Boehringer Ingelheim: We have been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units. We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.

Please note that the Connex clinical trial is full and the direct link to the study is no longer active.